-+ 0.00%
-+ 0.00%
-+ 0.00%

ELUTIA REPORTS THIRD QUARTER 2026 RESULTS: AS PLASTIC SURGEONS CITE INFECTION RISK IN EVERY BREAST RESEARCH SESSION DURING NATIONAL MEETING, NXT-41X HEADS TO FDA THIS QUARTER, FULLY FUNDED THROUGH LAUNCH

Reuters·11/05/2026 21:17:45

Please log in to view news